28 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
7 Aug 23
Maravai Lifesciences Reports Second Quarter 2023 Financial Results
4:19pm
to serve as Executive Chair of the Board of Directors;
Appointed medical technology expert Dr. John DeFord to the Board of Directors;
Took occupancy
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
20 Jul 23
Maravai LifeSciences Announces Appointment of New Director to the Board
4:08pm
associated with that role. Dr. DeFord, a medical technology expert, was appointed to fill the vacancy.
Dr. DeFord is the Chairman, Chief Executive Officer
8-K
EX-10.3
mq2 2hwhaughi1y4
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.1
txw50u4lxg2j
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.2
r2lu95s87k64ygyd
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-3.2
eyn500 1g
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
424B4
14juff m4lwxnkjfp8
23 Nov 20
Prospectus supplement with pricing info
4:36pm
S-1/A
EX-10.9
qmapndz
9 Nov 20
IPO registration (amended)
2:05pm
S-1/A
EX-10.8
bk8hv4rdx57n uspx
9 Nov 20
IPO registration (amended)
2:05pm
S-1/A
EX-3.2
khobd41ind46 ljx7g
9 Nov 20
IPO registration (amended)
2:05pm
S-1/A
EX-10.12
56eriih
9 Nov 20
IPO registration (amended)
2:05pm
S-1/A
EX-10.10
tmv0x8bnx1zra iq2r
9 Nov 20
IPO registration (amended)
2:05pm
S-1
EX-10.22
eaiv8m
29 Oct 20
IPO registration
5:04pm
S-1
EX-10.20
k57xtiwp
29 Oct 20
IPO registration
5:04pm
S-1
EX-10.21
k53jbdg5z1jd3dsk8
29 Oct 20
IPO registration
5:04pm
S-1
l9ss9w ikdwnl1i
29 Oct 20
IPO registration
5:04pm